Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0158 | 0.0292 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.079 | 0.5406 | 1 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.1456 | 1 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.005 | 0.0038 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.0147 | 0.0271 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.1456 | 1 | 1 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.1456 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.004 | 0.0028 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.079 | 0.5406 | 1 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.1456 | 1 | 0.5 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.1456 | 1 | 1 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.079 | 0.5406 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 0.0135 | 0.0123 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.079 | 0.5406 | 1 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.1456 | 1 | 1 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0013 | 0.004 | 0.0074 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0028 | 0.0147 | 0.0135 |
Echinococcus granulosus | lamin | 0.0027 | 0.0135 | 0.0249 |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 0.0135 | 0.0249 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0012 | 0.0022 |
Schistosoma mansoni | intermediate filament proteins | 0.0027 | 0.0135 | 0.0249 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0013 | 0.004 | 0.0074 |
Echinococcus granulosus | cpg binding protein | 0.003 | 0.0158 | 0.0292 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.1456 | 1 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.079 | 0.5406 | 0.5401 |
Onchocerca volvulus | 0.0028 | 0.0147 | 0.0012 | |
Brugia malayi | CXXC zinc finger family protein | 0.0028 | 0.0147 | 0.0136 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.1456 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 0.0135 | 0.0123 |
Schistosoma mansoni | lamin | 0.0027 | 0.0135 | 0.0249 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.079 | 0.5406 | 0.5401 |
Schistosoma mansoni | lamin | 0.0027 | 0.0135 | 0.0249 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0012 | 0.0022 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0158 | 0.0292 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.079 | 0.5406 | 1 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0402 | 0.2729 | 0.5047 |
Onchocerca volvulus | 0.1456 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0135 | 0.0123 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.1456 | 1 | 0.5 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.079 | 0.5406 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 0.0135 | 0.0249 |
Echinococcus granulosus | dnaJ subfamily B | 0.0402 | 0.2729 | 0.5047 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0131 | 0.012 |
Echinococcus multilocularis | musashi | 0.0027 | 0.0135 | 0.0249 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 0.0135 | 0.0249 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.079 | 0.5406 | 1 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0014 | 0.005 | 0.0039 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.1456 | 1 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.006 | 0.0365 | 0.0675 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.079 | 0.5406 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.079 | 0.5406 | 0.5401 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.079 | 0.5406 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.003 | 0.0158 | 0.0292 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.079 | 0.5406 | 0.5401 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 0.0135 | 0.0124 |
Echinococcus multilocularis | lamin | 0.0027 | 0.0135 | 0.0249 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0037 | 0.0025 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.1456 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0402 | 0.2729 | 0.5047 |
Brugia malayi | intermediate filament protein | 0.0027 | 0.0135 | 0.0124 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.1456 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0037 | 0.0025 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.079 | 0.5406 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.